January 2017
Volume 12 Issue 1 |
|
|
|
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
API Synthesis and Manufacturing
Alternatives to expensive palladium catalysts are gaining acceptance for commercial API synthesis.
/ read more /
DuPont received a grant from the Bill & Melinda Gates Foundation to produce pharmaceutical proteins.
/ read more /
Saneca Pharma has received a EUR1.5 million grant from the Slovak Ministry of Education, Science, Research, and Sport, which will be used to drive forward new R&D initiatives for API manufacturing.
/ read more /
|
|
|
ADVERTISEMENT
Pharmaceutical Technology's PharmaMarketplace
Your Connection to Global Pharmaceutical Manufacturing Suppliers
 Check it out today! |
|
|
|
Outsourcing Update
With a healthy supply of biosimilars heading to the approval pipeline, will license holders turn to contract manufacturers for development and production?
/ read more /
|
|
|
ADVERTISEMENT
PARTICIPATE! Need your input for BioPlan's 14th Annual Global Biopharmaceutical Manufacturing Study
BioPlan will donate $10 (up to $2,000) on your behalf to global health charities - Be the first to receive a FREE Aggregated Summary of this year's results AND receive our UPDATED 15 Top Trends in Biopharmaceutical Manufacturing White Paper.
 Learn more |
|
|
|
Supply Chain Update
TraceLink's first Drug Supply, Safety and Traceability Report suggests that 19% of pharma companies, 11% of distributors, and 9% of dispensers still haven't begun to address lot-level serialization requirements. Only 20% say their CMOs will be ready for the November 2017 deadline.
/ read more /
The two companies have entered into an agreement to provide Suzeken with access to AmerisourceBergen's Cubixx inventory solution.
/ read more /
|
|
|
In the Lab
The company increased its stability storage and distribution to address customer demand.
/ read more /
|
|
|
Contract Services Update
Pharma Tech introduced a new high-speed bottling line to its facility in Union, MO.
/ read more /
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
/ read more /
Novasep's three facilities located in France and Germany are free of Form 483.
/ read more /
The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials.
/ read more /
The companies entered into a manufacturing agreement for voclosporin active pharmaceutical ingredient.
/ read more /
The $2-billion facility will be located in Clayton, North Carolina.
/ read more /
Lonza adds CDMO, capsule, and consumer healthcare and nutrition capabilities with $5.5-billion acquisition of Capsugel.
/ read more /
|
|
|
|
|
